Journal
Frontiers in Oncology
Publication Date
2017
Volume
7
Inclusive Pages
178
Document Type
Open Access Publication
DOI
10.3389/fonc.2017.00178
Rights and Permissions
Hassanzadeh C, Rao YJ, Chundury A, Rowe J, Ponisio MR, Sharma A, Miller-Thomas M, Tsien CI and Ippolito JE (2017) Multiparametric MRI and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Is a Potential Prognostic Imaging Biomarker in Recurrent Glioblastoma. Front. Oncol. 7:178. doi: 10.3389/fonc.2017.00178 © 2017 Hassanzadeh, Rao, Chundury, Rowe, Ponisio, Sharma, Miller-Thomas, Tsien and Ippolito. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Hassanzadeh, Comron; Rao, Yuan James; Chundury, Anupama; Rowe, Jackson; Ponisio, Maria Rosana; Sharma, Akash; Miller-Thomas, Michelle; Tsien, Christina I.; and Ippolito, Joseph E., "Multiparametric MRI and [18F]fluorodeoxyglucose positron emission tomography imaging is a potential prognostic imaging biomarker in recurrent glioblastoma." Frontiers in Oncology. 7, 178. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/6195
Table 1
image 1.tif (32 kB)
Image 1
image 2.tif (22 kB)
Image 2
image 3.tif (26 kB)
Image 3
